Salix Pharmaceuticals to Present at BofA Merrill Lynch 2013 Health Care Conference
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the
Company will present at the BofA Merrill Lynch 2013 Health Care
Conference in Las Vegas, NV on Tuesday, May 14 at 4:20 p.m. PT (7:20
p.m. ET).
Interested parties can access a live audio web cast of the presentation
at http://www.salix.com.
A replay of the presentation will be available at the same location.
Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina,
develops and markets prescription pharmaceutical products for the
treatment of gastrointestinal diseases. Salix’s strategy is to
in-license late-stage or marketed proprietary therapeutic drugs,
complete any required development and regulatory submission of these
products, and market them through the Company’s gastroenterology
specialty sales and marketing team.
Salix trades on the NASDAQ Global Select Market under the ticker symbol
“SLXP”.
For more information, please visit our Website at www.salix.com
or contact the Company at 919-862-1000. Follow us on Twitter
(@SalixPharma) and Facebook (www.facebook.com/SalixPharma).
Information on our Twitter feed, Face book page and web site is not
incorporated in our SEC filings.
